Literature DB >> 8339736

Localization of hepatic metastases by radiolabelled anti-carcinoembryonic antigen antibody and meta-iodobenzylguanidine in a patient with medullary thyroid carcinoma.

K Liewendahl1, M Välimäki, M Taavitsainen.   

Abstract

Sonography, computed tomography and magnetic resonance imaging examinations did not detect recurrence or metastases of medullary thyroid carcinoma (MTC) in a patient with a rapidly rising serum calcitonin concentration after total thyroidectomy. Scintigraphy with technetium-99m labelled anti-carcinoembryonic antigen antibody, 99mTc-colloid and iodine-131 metaiodobenzylguanidine indicated liver metastases. The three scintigrams were to some extent discrepant but from the combined information the diagnosis of hepatic metastases could be established; it was subsequently verified by sonography and aspiration biopsy. This case demonstrates the usefulness of applying nuclear medicine imaging methods for the localization of hepatic MTC metastases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8339736     DOI: 10.1007/bf00175167

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  11 in total

1.  Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.

Authors:  S E Clarke; C R Lazarus; P Wraight; C Sampson; M N Maisey
Journal:  J Nucl Med       Date:  1988-01       Impact factor: 10.057

2.  Imaging of medullary carcinoma of the thyroid using 111In-labelled anti-CEA monoclonal antibody fragments.

Authors:  K J O'Byrne; D Hamilton; I Robinson; E Sweeney; P J Freyne; M J Cullen
Journal:  Nucl Med Commun       Date:  1992-03       Impact factor: 1.690

3.  Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.

Authors:  J P Vuillez; P Peltier; J P Caravel; A Chetanneau; J C Saccavini; J F Chatal
Journal:  J Clin Endocrinol Metab       Date:  1992-01       Impact factor: 5.958

4.  Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment.

Authors:  C Reiners; C Eilles; W Spiegel; W Becker; W Börner
Journal:  Nuklearmedizin       Date:  1986-12       Impact factor: 1.379

5.  Imaging of medullary thyroid cancer with 131I-MIBG.

Authors:  K Endo; K Shiomi; K Kasagi; J Konishi; K Torizuka; K Nakao; H Tanimura
Journal:  Lancet       Date:  1984-07-28       Impact factor: 79.321

6.  Radioimmunoimaging of metastatic medullary carcinoma of the thyroid gland using an indium-111-labeled monoclonal antibody to CEA.

Authors:  H D Edington; C G Watson; G Levine; W N Tauxe; S A Yousem; M Unger; C D Kowal
Journal:  Surgery       Date:  1988-12       Impact factor: 3.982

7.  New tracers for the imaging of the medullary thyroid carcinoma.

Authors:  U P Guerra; C Pizzocaro; A Terzi; R Giubbini; G Maira; R Pagliaini; M Bestagno
Journal:  Nucl Med Commun       Date:  1989-04       Impact factor: 1.690

8.  Scintigraphy and treatment of medullary carcinoma of the thyroid with iodine-131 metaiodobenzylguanidine.

Authors:  S E Clarke; C R Lazarus; S Edwards; B Murby; D G Clarke; T M Roden; I Fogelman; M N Maisey
Journal:  J Nucl Med       Date:  1987-12       Impact factor: 10.057

9.  Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen.

Authors:  C Berche; J P Mach; J D Lumbroso; C Langlais; F Aubry; F Buchegger; S Carrel; P Rougier; C Parmentier; M Tubiana
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-20

10.  Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.

Authors:  T Sone; M Fukunaga; N Otsuka; R Morita; A Muranaka; S Yanagimoto; T Tomomitsu; H Nakayama; T Harada
Journal:  J Nucl Med       Date:  1985-06       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.